GlaxoSmithKline compound 5h [PMID:20542694] [3686]
GlaxoSmithKline compound 5h [PMID:20542694]
| SMILES |
CCCCCc1ccc(NC(=O)Nc2cccc3cc(-c4ccccc4C(C)C)oc23)cc1 |
| InChIKey |
ASCJIAKBYVUVNZ-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors |
2 |
| Hydrogen bond donors |
2 |
| Rotatable bonds |
8 |
| Log P |
8.600 |
| Molecular weight (Da) |
440.2 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
GlaxoSmithKline compound 5h [PMID:20542694]
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.